Livtencity
Payments companies reported to CMS as associated with Livtencity. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Livtencity, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Livtencity
These are the largest totals companies reported as associated with Livtencity. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Cedric Spak | Fort Worth, TX | Infectious Disease | $160,067.91 |
| Sridhar Allam | Mcallen, TX | Transplant Surgery | $122,807.92 |
| Juan Diaz | Altamonte Springs, FL | Infectious Disease | $109,773.96 |
| Muhammad Bilal Abid | Milwaukee, WI | Hospitalist | $64,175.13 |
| Suphamai Bunnapradist | Los Angeles, CA | Nephrology (Internal Medicine) | $63,671.18 |
| Sammy Saab | Los Angeles, CA | Gastroenterology (Internal Medicine) | $52,995.21 |
| Christopher Cooper | Altamonte Springs, FL | Infectious Disease | $51,884.49 |
| Rajat Walia | Phoenix, AZ | Pulmonary Disease | $38,889.22 |
| Josh Levitsky | Chicago, IL | Gastroenterology (Internal Medicine) | $38,291.95 |
| Alexander Wiseman | Denver, CO | Transplant Surgery | $37,008.31 |
Prescribed Livtencity?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.